An economic evaluation of anticipated costs and savings of a behavior change intervention to enhance medication adherence

Pharmacy Practice

Volumn 6, Issue 2, 2008, Pages 68-73

  Wiegand, Phillip N ^a   Wertheimer, Albert I ^a  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

Costs and cost analysis; Models, psychological; Patient compliance; United Estates

Indexed keywords

ANTIDIABETIC AGENT;

ARTICLE; BEHAVIOR CHANGE; COST BENEFIT ANALYSIS; COST CONTROL; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DRUG COST; HEALTH CARE COST; HEALTH CARE DELIVERY; HEART DISEASE; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; THEORETICAL MODEL;

EID: 50649087781     PISSN: None     EISSN: 18863655     Source Type: Journal    
DOI: 10.4321/S1886-36552008000200002     Document Type: Article

References (25)

1. Cramer JA, Pugh MJ. The influence of insulin use on glycemic control: How well do adults follow prescriptions for insulin?. Diabetes Care. 2005 Jan;28(1):78-83.
2. Cramer JA.. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218-1224.
3. Ribeiro MJ. Compliance with guidelines for elderly patients undergoing cancer therapy. J Clin Oncology 2004;22(14S Supplement): 6148
4. Haynes RB, Yao X, Degani A, Kripalani S, Garg A, McDonald HP. Interventions to enhance medication adherence. Cochrane Database Syst Rev. 2005;(4):CD000011.
5. Vermeire E, Wens J, Van Royen P, Biot Y, Heamshaw H, Lindenmeyer A. Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005;(2):CD003638.
6. Schedlbauer A, Schroeder K, Peters TJ, Fahey T. Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev. 2004;(4):CD004371.
7. Schroeder K, Fahey T, Ebrahim S. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev. 2004;(2):CD004804.
8. Rueda S, Park-Wyllie LY, Bayoumi AM, Tynan AM, Antoniou TA, Rourke SB, Glazier RH. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Cochrane Database Syst Rev. 2006;3:CD001442.
9. Golin CE, Earp J, Tien HC, Stewart P, Porter C, Howie L. A 2-arm, randomized, controlled trial of a motivational interviewing-based Intervention to improve adherence to antiretroviral therapy (ART) among patients falling or initiating ART. J Acquir Immune Defic Syndr. 2006;42(1):42-51.
10. Pradier C, Bentz L, Spire B, Tourette-Turgis C, Morin M, Souville M, Rebillon M, Fuzibet JG, Pesce A, Dellamonica P, Moatti JP. Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study. HIV Clin Trials. 2003 Mar-Apr;4(2):121-31.
11. Fava JL, Velicer WF, Prochaska JO.. Applying the transtheoretical model to a representative sample of smokers. Addict Behav. 1995;20(2):189-203.
12. DiClemente CC, Prochaska JO, Fairhurst SK, Velicer WF, Velasquez MM, Rossi JS. The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol. 1991;59(2):295-304.
13. Prochaska JO, DiClemente CC, Velicer WF, Rossi JS. Standardized, individualized, interactive, and personalized self-help programs for smoking cessation. Health Psychol. 1993;12(5):399-405.
14. Prochaska JO, Velicer WF, Redding C, Rossi JS, Goldstein M, DePue J, Greene GW, Rossi SIR, Sun X, Fava JL, Laforge R, Rakowski W, Plummer BA. Stage-based expert systems to guide a population of primary care patients to quit smoking, eat healthier, prevent skin cancer, and receive regular mammograms. Prev Med. 2005;41(2):406-416.
15. Prochaska JO, Velicer WF, Rossi JS, Redding CA, Greene GW, Rossi SR, Sun X, Fava JL, Laforge R, Plummer BA. Multiple risk expert systems interventions: impact of simultaneous stage-matched expert system interventions for smoking, high-fat diet, and sun exposure in a population of parents. Health Psychol. 2004;23(5):503-516.
16. Vallis M, Ruggiero L, Greene G, Jones H, Zinman B, Rossi S, Edwards L, Rossi JS, Prochaska JO.. Stages of Change for Healthy Eating in Diabetes. Diabetes Care 2003;26:1468-1474.
17. Jones H, Edwards L, Vallis TM, Ruggiero L, Rossi SR, Rossi JS, Greene G, Prochaska JO, Zinman B; Diabetes Stages of Change (DISC) Study. Changes in diabetes self-care behaviors make a difference in glycemic control: the Diabetes Stages of Change (DiSC) study. Diabetes Care. 2003;26(3):732-737
18. Sarkin JA, Johnson SS, Prochaska JO, Prochaska JM. Applying the transtheoretical model to regular moderate exercise in an overweight population: validation of a stages of change measure. Prev Med. 2001;33(5):462-469.
19. Velicer WF, Rossi JS, Ruggiero L, Prochaska JO. Minimal Interventions Appropriate for an Entire Population of Smokers. Interventions for Smokers: An International Perspective. Ed. Robyn Richmond. Baltimore: Williams & Wilkins, 1994. 69-92.
20. Prochaska J. Stages of Change. Psychotherapy 2001;38(4).
21. Prochaska JO.. Strong and weak principles for progressing from precontemplation to action on the basis of twelve problem behaviors. Health Psychol. 1994;13(1):47-51.
22. Morsanutto A, Berto P, Lopatriello S, Voinovich D, Gelisio R, Mantovani LG. Major diabetes complications have an impact on total annual medical cost of type 2 diabetes. Diabetes Care. 2004;27(7):1841-1842.
23. Rathmann W, Haastert B, Icks A, Giani G. Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994-2004. Diabetes Care. 2007;30(4):848-853.
24. Caro JJ, Ward AJ, O'Brien JA. Lifetime costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care. 2002;25(3):476-481
25. Brandle M, Zhou H, Smith BR, Marriott D, Burke R, Tabaei BP, Brown MB, Herman WH.. The direct medical cost of type 2 diabetes Diabetes Care. 2003;26(8):2300-2304.